Fact is facts are being exposed and Bumbling Biden is toast

New Post Public Reply Private Reply Replies (0) Message Board
Rusty Bhawks #75593
330
Fact is facts are being exposed and Bumbling Biden is toast along with his son and Fraud Fauci.

Dr. Fauci Claimed Yesterday that His Financials Were Available But These Claims “Just Aren’t True”.

Dr. Fauci was not forthright when he claimed yesterday in front of the Senate that his financials were widely available. Dr. Fauci may be hiding his financials because of potential multi-million dollar royalties he’s received over the years on vaccines.
Yesterday, Dr. Anthony Fauci was questioned under oath by U.S. Senator Roger Marshall (R-KS). One topic regarded Fauci’s income and financial and conflict disclosures.

We’ve reported previously that Fauci is the highest-paid employee in the US government.

What an outrage, the same guy who cost millions of Americans their jobs is the highest paid employee in the US government.
Forbes reported yesterday that Dr. Fauci is the highest paid individual in the US Government:

Dr. Anthony Fauci made $417,608 in 2019, the latest year for which federal salaries are available. That made him not only the highest paid doctor in the federal government, but the highest paid out of all four million federal employees.

In fact, Dr. Fauci even made more than the $400,000 salary of the President of the United States. All salary data was collected by OpenTheBooks.com via Freedom of Information Act requests.

Only federal employees whose salaries were funded by taxpayers were included in the study. Therefore, Tennessee Valley Authority CEO Jeffrey Lyash— whose salary is paid by revenues of the corporation (owned by the federal government) — was not included.

Dr. Fauci has been in the government for a long time but most Americans never heard of the guy till this year. It’s been reported that Dr. Fauci is due to make more from the vaccines he promotes but he has denied this:

In an August 13, 2020 Instagram interview with actor Matthew McConaughey, Dr. Fauci was asked (at point 16:49) if he had millions of dollars invested in the vaccines. Dr. Fauci laughed and answered, “Matthew, no, I got zero! I am a government worker. I have a government salary.” He didn’t mention his $417,608 salary was the largest in the entire federal government.

But Bobby Kennedy Jr. reported that Fauci was going to make money on the vaccines: In New Interview Bobby Kennedy Jr. Claims Dr. Fauci will Make Millions on Coronavirus Vaccine and Owns Half the Patent

Robert Kennedy Jr. and Harvard Attorney Alan Dershowitz debated on the topic of the coronavirus vaccine back in July.
During the debate, Kennedy Jr. claimed that Dr. Anthony Fauci invested $500 million in the vaccine that is not safe by any means and Fauci owns half the patent so he’s due to make millions.

In an earlier thread we reported on Bobby Kennedy Jr.’s comments about Big Pharma and the increase in vaccines in our culture back in April.

Kennedy shared the story of how Dr. Fauci fired and led the indictment of a brilliant assistant who blew the whistle on the harmful consequences attributed to vaccines.

We also reported on this doctor, Dr. Judy Mikovits who was a young doctor with a promising career until she began raising concerns about what she considered to be the potentially harmful consequences of vaccines.
Dr. Mikovits explained how she was jailed during this time period with charges related to her removal of lab notebooks, a computer, and other material belonging to the institute. These charges were ultimately dropped. Her video has since been taken down by YouTube.


Kennedy thanked Dershowitz for joining him and then stated that when he was young, Americans had faith in the medical community but now roughly 50% of Americans don’t want to take a coronavirus vaccine. The reason for this may be because the actual rate of serious harm from vaccines is 2.4%. There’s a 1 in 40 chance that you will get injured by vaccines and today’s kids have to take up to 70 vaccines.

Big Pharma was protected from being sued for their vaccines which is why they exploded in use. So now today not a single vaccine has been tested against a placebo and Big Pharma is pushing through the coronavirus vaccine at a record pace, despite numerous individuals in the initial testing sample getting violently ill and the testing given to the healthiest people in the country.

The problem is Anthony Fauci put $500 million of our dollars into that vaccine. He owns half the patent. He and these five guys who are working for him were entitled to collect royalties from that.

So you have a corrupt system and now they have a vaccine that is too big to fail. And instead of saying this was a terrible, terrible mistake, they are saying we are going to order 2 billion doses of this and you’ve got to understand Alan with these COVID vaccines these companies are playing with house money. They’re not spending any dime, they have no liability. Well if they kill 20 people or 200 people or 2,000 people in their clinical trials, big deal. They have zero liability. And guess what, they’ve wasted none of their money because we’re giving them money to play with.




https://www.thegatewaypundit.com/2020/08/unbe...lf-patent/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 1

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 2

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 1

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 1

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 2

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
GoPro's $1.14 Buyout Scrutinized: Fair Value Debate

Updated Category News Views 2

Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 5

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading